Skip to main content
SpringerLink
Log in

Alectinib/ceritinib/crizotinib

Drug-induced lung injury: 7 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Koshikawa K, et al. Clinical characteristics and risk factors of drug-induced lung injury by ALK tyrosine kinase inhibitors: A single center retrospective analysis. Thoracic Cancer 11: 1495-1502, No. 6, Jun 2020. Available from: URL: http://doi.org/10.1111/1759-7714.13416

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alectinib/ceritinib/crizotinib. Reactions Weekly 1811, 19 (2020). https://doi.org/10.1007/s40278-020-80242-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80242-0

Search

Navigation